Full report: The State of Public Health in Canada 2026
Download in PDF format
(2.26 MB, 35 pages)
Cat.: HP2-10E-PDF
ISBN: 1924-7087
Pub.: 260295
Chief Public Health Officer of Canada's Report
Published: October 2026
On this page
- Message from the Chief Public Health Officer of Canada
- About this report
- Key trends in national population health
- Looking forward
- Methodology
- Acknowledgements
- References
Message from the Chief Public Health Officer of Canada
Canada's Chief Public Health Officer
Since becoming Canada's Chief Public Health Officer (CPHO), I've been connecting with and learning from people and partners across the country. Those conversations have reinforced for me the importance of sharing accurate and reliable information about the health issues affecting our communities. I hope this report contributes to that effort by providing a snapshot of key trends in Canada.
The trends highlighted here have caught my attention because of what they tell us about the health of our populations. While every community is unique, looking at the national picture helps us see shared patterns. The report examines some of these by exploring recent changes in life expectancy, mental health, toxic drug harms, sexually transmitted and blood-borne infections, measles, cancer, and wildfires.
While these topics offer important insights into population health, they do not provide a comprehensive overview. Many other issues, including vector-borne and other zoonotic diseases, antimicrobial resistance, tuberculosis, chronic diseases, digital environments, and health security, remain significant public health priorities. I look forward to continuing to explore, address, and report on these areas in the future.
As I reflect on where we are today, and consider the trends in this report, a few observations stand out to me.
Concerning trends among younger people have important implications for both current and future health. The experiences of young people today will shape their health for years to come, underscoring the importance of supporting health early on and throughout the life course.
Some groups continue to experience worse health outcomes than others. These inequities are driven by the social determinants of health, such as income and housing, and structural determinants, such as systemic racism and colonialism. Together, these factors create advantages for some people and disadvantages for others. Because many public health issues share these underlying drivers, improving health outcomes requires collaboration across communities, sectors, and systems.
The way we measure and report on health may not always reflect the experiences of all communities or populations in Canada. For example, population health indicators may not fully capture the holistic and relational understandings of health and wellness shared among many First Nations, Inuit, and Métis Peoples. We can better support well-being and advance equity by continuing to integrate positive and strengths-based ways of measuring health.
My experience has shown me that addressing many of the issues highlighted in this report depends on our ability to work together. This becomes even more important as climate change, new technologies, and the spread of misinformation and disinformation reshape how we live, with important implications for our health. Strong relationships and sustained trust are critical in this context.
While trust is built in communities and through people's everyday experiences, I believe an important part of my role is working to foster that trust. This includes sharing clear, relevant, and accurate health information, and being transparent about what we know and what we are still learning. It also means listening to diverse perspectives and lived experiences from across the country.
Public health efforts often happen behind the scenes, but they make a big difference to people's lives. I want to thank the public health professionals, researchers, community organizations, and many others whose dedication and resilience make this work possible. They continue to meet urgent needs while also digging deeper to better understand what drives and improves health outcomes. This report reflects some of what we are learning, and those lessons will continue to shape how we approach the path ahead. I look forward to working together to build healthy communities.
Dr. Joss Reimer
Canada's Chief Public Health Officer
About this report
Each year, the CPHO reports on important issues influencing the state of public health in Canada. The 2026 report highlights select examples of trends in population health and draws upon the best available national evidence to briefly explore key context, drivers, and inequities. It is intended to be a snapshot of some key trends and focuses on seven areas with notable recent developments:
- Life expectancy and health-adjusted life expectancy
- Mental health
- Toxic drug harms
- Sexually transmitted and blood-borne infections
- Measles
- Cancer
- Wildfires
The selected topics represent the diversity and evolving nature of health and well-being in Canada. While national indicators offer valuable insight into broad patterns, they cannot fully capture the complexity of population health and should be interpreted alongside additional evidence, research, and community knowledge.
The report is intended for a range of audiences interested in national population health, including public health professionals, policymakers, researchers, community stakeholders, and partners across relevant sectors.
The report is organized by topic area. Each section summarizes key recent trends (What is changing?) and considers their implications for public health (Why does this matter?). These are followed by a concluding Looking forward section that highlights CPHO priorities.
Additional resources
Readers interested in exploring the issues discussed in this report in greater depth, or in accessing additional national public health data, are encouraged to consult the following resources:
- Health of People in Canada Dashboard
- Health Inequalities Data Tool
- Quality of Life Hub
- Positive Mental Health Surveillance Indicator Framework
- Canadian Chronic Disease Surveillance System
- Opioid- and Stimulant-related Harms in Canada
- Canadian Notifiable Disease Surveillance System
- Canadian Wildland Fire Information System
Land and water acknowledgement
This report was developed on the traditional lands and waters of First Nations, Inuit, and Métis Peoples across what is now known as Canada. We wish to acknowledge the strength, resilience, and wisdom of Indigenous Knowledges that have been nurtured and passed down through generations by First Nations, Inuit, and Métis Peoples. We also wish to acknowledge the following lands and waters, where the core work on this report was undertaken:
- Halifax, also known as K'jipuktuk, which is part of the ancestral, unceded, and unsurrendered territory of the Mi'kmaq People. The area and its connection to the Atlantic Ocean have sustained the Mi'kmaq People since time immemorial and continue to hold deep cultural, spiritual, and ecological significance. This territory is covered by the Treaties of Peace and Friendship which Mi'kmaq, Wolastoqiyik (Maliseet), and Passamaquoddy Peoples signed between 1725 and 1779. The treaties did not deal with the surrender of lands and resources but, instead, recognized Mi'kmaq, Wolastoqiyik (Maliseet), and Passamaquoddy title and established the rules for an ongoing relationship of peace and friendship between nations.
- Montreal, also known as Tiohtià:ke, the traditional, unceded, and unsurrendered territory of the Kanien'kehá:ka. Montreal is now home to many diverse urban First Nations, Inuit, and Métis Peoples. Located along the Kaniatarowanenneh (St. Lawrence River), Tiohtià:ke has long been a place of gathering, travel, trade, and exchange, serving as an important meeting place for many First Nations, including the Kanien'kehá:ka of the Haudenosaunee Confederacy, Wendat, Abenaki, and Anishinaabeg.
- Ottawa, also known as Adawe, located on the traditional, unceded, and unsurrendered territory of the Anishinabe Algonquin People, including the members of the Anishinabek Nation Governance Agreement. Ottawa is now home to many diverse urban First Nations, Inuit, and Métis Peoples. Located where the Kichi Sìbì (Ottawa River) and Pasapkedjinawong (Rideau River) meet, this area has long been a place of gathering, travel, trade, and cultural exchange, with these waterways continuing to hold deep significance for the Algonquin People.
- Toronto, also known as Tkaronto, located on the traditional territory of many nations, including the Mississaugas of the Credit, the Anishinaabeg, the Chippewa, the Haudenosaunee, and the Wendat Peoples and is now home to many diverse urban First Nations, Inuit, and Métis Peoples. Situated along the northwestern shore of Niigani-gichigami (Lake Ontario) and connected through the waterways of the Great Lakes, Tkaronto has long been an important place of gathering, travel, and exchange. Toronto is within the lands protected by the Dish with One Spoon Wampum Belt Covenant, an agreement between the Haudenosaunee and Anishinaabeg and allied nations to peaceably share and care for the resources around the Great Lakes.
- New Westminster, located on the unceded and unsurrendered land of the traditional Halkomelem speaking peoples from the Coast Salish, and in particular the qiqéyt (Qayqayt) and xʷməθkʷəy̓əm (Musqueam) Nations. Situated along the Stó:lō (Fraser River), whose waters have sustained Coast Salish Peoples since time immemorial, these lands and waterways remain central to culture, governance, trade, and stewardship.
- Central Saanich, located on the traditional territory of the SȾÁUTW̱ and W̱JOȽEȽP First Nations, two of the five communities that constitute the W̱SÁNEĆ Nation. This area is also within the lands covered by the Douglas Treaties, specifically the South Saanich and North Saanich Treaties. The region is surrounded by the waters of the Á,LEṈENEȻ ȽTE (Salish Sea), including the SȾÁUTW̱ (Saanich Inlet) and Haro Strait. These marine waters have sustained the W̱SÁNEĆ Peoples since time immemorial and continue to be central to their culture, governance, and way of life.
Key trends in national population health
Public health systems at national, provincial, territorial, and regional levels collect and analyze information on physical and mental health outcomes, determinants of health, health-related behaviours, and health system use.Footnote 1Footnote 2Footnote 3Footnote 4 These data help detect emerging issues, monitor changes over time, and inform policies and programs that support population health. The trends presented in this report highlight selected areas that provide insight into how population health is changing in Canada.
Life expectancy is returning to pre-pandemic levels, but fewer years are spent in good health
What is changing?
Life expectancy at birth in Canada has been mostly increasing for the past century, but the pace of gains began to slow in 2010 as a result of the toxic drug crisis.Footnote 5Footnote 6Footnote 7 Between 2019 and 2022, life expectancy dropped from 82.2 years to 81.1 years, the largest decrease ever recorded in Canada.Footnote 5Footnote 8 The decline was likely driven by impacts of the COVID-19 pandemic, including both deaths directly attributable to COVID-19 and a rise in deaths related to the toxic drug crisis, particularly among younger men.Footnote 7Footnote 9Footnote 10
Recent data show a rebound. Life expectancy at birth has increased for two consecutive years, reaching 82.1 years in 2024, nearly returning to pre-pandemic levels (Figure 1).Footnote 11
Figure 1: Text description
The figure is a line graph showing life expectancy and health-adjusted life expectancy in Canada. The horizontal axis shows year, from 2000 to 2024, and the vertical axis shows the number of years. One trend line represents life expectancy and a second line represents health-adjusted life expectancy.
| Year | Life expectancy (years) | Health-adjusted life expectancy (years) |
|---|---|---|
| 2000 | 79.27 | Not available |
| 2001 | 79.51 | 68.50 |
| 2002 | 79.64 | Not available |
| 2003 | 79.82 | Not available |
| 2004 | 80.10 | Not available |
| 2005 | 80.22 | Not available |
| 2006 | 80.65 | 69.40 |
| 2007 | 80.65 | Not available |
| 2008 | 80.83 | Not available |
| 2009 | 81.18 | Not available |
| 2010 | 81.43 | Not available |
| 2011 | 81.58 | 70.40 |
| 2012 | 81.76 | Not available |
| 2013 | 81.84 | Not available |
| 2014 | 81.87 | Not available |
| 2015 | 81.92 | Not available |
| 2016 | 82.02 | 69.70 |
| 2017 | 81.88 | Not available |
| 2018 | 81.87 | Not available |
| 2019 | 82.22 | 68.80 |
| 2020 | 81.58 | 68.60 |
| 2021 | 81.50 | Not available |
| 2022 | 81.13 | Not available |
| 2023 | 81.68 | 66.90 |
| 2024 | 82.16 | Not available |
Notes: Health-adjusted life expectancy data prior to 2019 are three-year estimates plotted at their midpoint while data from 2019 to 2023 are single year estimates. Life expectancy data from 2000 to 2024 are single year estimates.
Just as important as how long people live is how healthy they are during those years. Health-adjusted life expectancy measures both the length and quality of life.Footnote 14 It estimates how many years a person is likely to live in good health if current patterns of mortality and health remain unchanged. This measure reflects the total time spent in good health across the lifespan, whether accumulated through consecutive or non-consecutive periods of good health.Footnote 14
Recent trends in health-adjusted life expectancy raise concern. In 2023, a person in Canada could expect to spend an average of 66.9 years in good health.Footnote 15 This is nearly two years lower than in 2019 and more than three years below the peak reached in the early 2010s, reversing gains made since the early 2000s (Figure 1).Footnote 15
New evidence points to deteriorating emotional health among people under the age of 65 as the primary contributor to this decline.Footnote 16 While the prevalence of high emotional health decreased across all adult age groups between 2015 and 2024, the largest declines were observed among younger adults, particularly those aged 18 to 34 years.Footnote 16
Why does this matter?
Life expectancy and health-adjusted life expectancy are central to understanding the health of a population. Health-adjusted life expectancy provides valuable context by capturing not only whether people are living longer, but also whether they are living well throughout their lives.
Ideally, gains in life expectancy would be accompanied by similar or greater gains in health-adjusted life expectancy. Instead, recent trends suggest that on average people in Canada are living longer while spending a smaller share of their lives in good health before age 65. This has implications for quality of life and highlights the need to support health and well-being throughout the life course.
These measures can also be used to examine health inequities across populations.Footnote 17 Life expectancy has been consistently shorter among First Nations, Inuit, and Métis Peoples than among the non-Indigenous population, influenced by the historic and ongoing impacts of colonialism, systemic racism, and intergenerational trauma on health.Footnote 18Footnote 19Footnote 20Footnote 21 While life expectancy improved among Indigenous Peoples between 2006 and 2019, progress was uneven, and substantial gaps remained.Footnote 20 Between 2016 and 2021, life expectancy was 13.6 years lower for First Nations living on-reserve, 9.0 years lower for First Nations living off-reserve, 13.1 years lower for Inuit, and 4.5 years lower for Métis.Footnote 21
There are also differences in life expectancy and health-adjusted life expectancy by income and sex. Nationally, in 2023, people living in the lowest income neighbourhoods lived five years less than people living in the highest income neighbourhoods and could expect to live eight years fewer in good health on average.Footnote 12 Although females consistently live longer in both total number of years and healthy years, males spend a greater proportion of their lives in good health (83% compared to 81%).Footnote 15
Examining these indicators across different populations helps identify where health gains are occurring and where systemic barriers to longer, healthier lives persist.
While some indicators of mental health have worsened, there are early signs they may be levelling off
What is changing?
Over the past decade, some mental health indicators have been worsening in Canada. In 2015, 72% of adults reported their mental health was very good or excellent, but in 2021 this dropped to 59%.Footnote 22 Similarly, for youth aged 12 to 17 years, this percentage was 78% in 2015 and dropped to 62% in 2021.Footnote 23Footnote 24 Declines in high perceived mental health did not appear to continue from 2023 to 2024.Footnote 25Footnote 26 While most people in Canada report high perceived mental health, and recent data suggest the trend may be stabilizing, levels remain below those seen a decade ago.Footnote 22
Similar trends were observed in rates of mood disorder and of anxiety disorder, the two most common types of mental illnesses, which both appeared to be increasing between 2015 and 2021.Footnote 22 For mood disorders, increases did not appear to continue between 2023 and 2024 (similar analysis for anxiety disorders was not feasible as a result of data limitations).Footnote 25 Continued collection of comparable data is needed to determine whether these early signals reflect a true change in prevalence and whether the trend will continue in the future.
There are also differences in mental health between population groups that have emerged recently. For example, while there have been declines among all age groups, due to larger declines over time among younger adults, adults 65 years and older are now the most likely to report high perceived mental health (Figure 2).Footnote 25 Additionally, for youth aged 12 to 17 years, males and females were more similar in 2015 than in more recent years, where estimates of high perceived mental health are considerably lower for females (Figure 2).Footnote 23Footnote 26 Young women in particular are most likely to meet the diagnostic criteria for a mood or anxiety disorder.Footnote 27
Figure 2: Text description
The figure contains two graphs showing the percentage of people in Canada who reported high perceived mental health. The graph on the left is a grouped bar graph comparing 2015 and 2024 across four adult age groups: 18 to 34 years, 35 to 49 years, 50 to 64 years, and 65 years and older. The graph on the right is a line graph showing youth aged 12 to 17 years from 2015 to 2024, with separate trend lines for males and females. The vertical axes show percentage. Each sex is represented by two connected line segments, separated by a single data point in 2022 where comparable data are not available.
| Age group | 2015 (%) | 2024 (%) |
|---|---|---|
| 18 to 34 years | 72.5 | 47.4 |
| 35 to 49 years | 72.4 | 51.0 |
| 50 to 64 years | 72.0 | 55.5 |
| 65 years and older | 70.5 | 62.9 |
| Year | Males (%) | Females (%) |
|---|---|---|
| 2015 | 80.2 | 75.6 |
| 2016 | 79.1 | 75.5 |
| 2017 | 79.6 | 72.2 |
| 2018 | 78.5 | 69.5 |
| 2019 | 79.0 | 66.7 |
| 2020 | 76.2 | 61.0 |
| 2021 | 72.1 | 52.2 |
| 2022 | 68.7 | 47.1 |
| 2023 | 68.6 | 47.8 |
| 2024 | 71.0 | 52.7 |
Notes: For adults all estimates are from the Canadian Community Health Survey. For youth (12 to 17 years of age) estimates from 2015 to 2022 are from the Canadian Community Health Survey and estimates from 2023 to 2024 are from the Canadian Health Survey on Children and Youth. As a result of a survey redesign, caution is needed when comparing Canadian Community Health Survey data before and after 2022. Estimates from the Canadian Community Health Survey and the Canadian Health Survey on Children and Youth should not be compared because of different sampling and data collection methodologies.
Why does this matter?
Good mental health supports overall health and the ability of individuals, communities, and societies to function and thrive.Footnote 28Footnote 29Footnote 30 Therefore, any changes in mental health can have broad implications, underscoring the importance of understanding how these trends may shape health and well-being over time.
Part of the overall worsening seen in the past decade may reflect greater awareness and openness around mental health, which could make people more willing to report worse mental health.Footnote 31Footnote 32Footnote 33Footnote 34 However, evidence suggests these factors alone do not fully explain the trends seen in Canada and some comparable countries, particularly among younger people.Footnote 32Footnote 35Footnote 36Footnote 37 Understanding what is driving these changes remains an ongoing area of research. It is likely that multiple, interconnected forces are at play, including broader global challenges, such as the climate crisis, economic instability and affordability challenges, changing digital environments, and lasting impacts of the COVID-19 pandemic.Footnote 35Footnote 36Footnote 37Footnote 38Footnote 39
Some groups of people experience significantly worse mental health than others, reflecting the influence of the social and structural determinants of health.Footnote 40 As a result, certain populations are exposed to more risk factors (e.g., discrimination, financial difficulties, food insecurity) and fewer protective factors (e.g., access to culturally safe mental healthcare services).Footnote 28Footnote 40Footnote 41Footnote 42Footnote 43 This leads to inequities in mental health outcomes.Footnote 28Footnote 40Footnote 42
It is important to note that although there is no singular Indigenous perspective on mental health, for many First Nations, Inuit, and Métis populations, mental wellness is often understood holistically, and supported by community, culture, family, language, land, Elders, and connection to traditional practices.Footnote 44 These dimensions of wellness may not be fully reflected in conventional Western mental health indicators.Footnote 42Footnote 44Footnote 45
As the unregulated drug supply changes, so do its health harms
What is changing?
Canada has witnessed a substantial rise in fatal and non-fatal harms associated with toxicity in the unregulated drug supply between 2016 and 2023.Footnote 46 This was largely driven by the introduction of fentanyl and other synthetic opioids.Footnote 46Footnote 47 A notable decline in fatalities has since occurred nationally, with a 17% decrease in apparent opioid toxicity deaths between 2023 and 2024, and a further 23% decrease from 2024 to 2025.Footnote 48 This trend varies significantly by region.Footnote 48
The national decline in fatalities appears to be influenced by multiple factors, including changes in the toxicity of the drug supply and better access to naloxone.Footnote 49 However, the unregulated drug supply remains highly toxic and unpredictable, driving continued risk. For example, a number of public health authorities across Canada published drug alerts in early 2026 flagging new contaminants.Footnote 50Footnote 51Footnote 52 While naloxone is recommended for all overdoses, additional medical interventions may be needed to address any effects of these new contaminants which naloxone does not directly reverse.Footnote 53 Changes in the drug supply can also alter the risk of non-fatal harms, such as brain injury or infection.Footnote 54Footnote 55Footnote 56Footnote 57
Another shift during the toxic drug crisis has been the rise in polysubstance exposure, which is when more than one substance or drug is taken together, either intentionally or unintentionally. There has been an increase in deaths involving multi-drug toxicity, particularly those involving both opioids and stimulants.Footnote 58Footnote 59Footnote 60Footnote 61
Why does this matter?
The toxic drug crisis has had innumerable impacts on individuals, families, healthcare providers, and communities. This impact is ongoing, with 2025 apparent opioid toxicity deaths still higher than pre-pandemic levels in 2019, and almost twice as high as those observed at the beginning of the crisis in 2016.Footnote 48 Opioid-related emergency department visits, hospitalizations, and emergency medical services calls have also remained high.Footnote 46 This underscores the need to sustain and strengthen comprehensive prevention, harm reduction, and treatment efforts.Footnote 62Footnote 63
Furthermore, shifting trends in the supply of unregulated substances make it difficult to predict the nature and severity of future harms. This may impact the relevance and effectiveness of public health interventions, reinforcing the value of learning from people with lived and living experience.Footnote 64Footnote 65Footnote 66Footnote 67
Understanding how these evolving harms are experienced across populations can inform effective public health responses. People who use drugs can come from all walks of life. However, the harms of the crisis fall more heavily on men, and inequitable outcomes are influenced by a number of social determinants of health, including income, housing, employment, and education.Footnote 46Footnote 67Footnote 68Footnote 69Footnote 70Footnote 71Footnote 72
First Nations, Inuit, and Métis populations are also disproportionately harmed by the toxic drug crisis due to ongoing impacts of colonialism, racism, and intergenerational trauma.Footnote 73Footnote 74 Indigenous and public health leaders have highlighted the need for Indigenous-led approaches, partnerships with Indigenous organizations, and culturally safe care that centres Indigenous Knowledges.Footnote 62Footnote 63Footnote 73Footnote 75Footnote 76Footnote 77
Rates of some sexually transmitted and blood-borne infections continue to rise
What is changing?
Over the past decade, patterns in sexually transmitted and blood-borne infections (STBBIs) have shifted. National rates of syphilis, chlamydia, and gonorrhea are increasing (Figure 3). In particular, infectious syphilis has risen substantially over the past decade, with more than a four-fold increase in rates between 2014 and 2023.Footnote 78 This surge has led to a more than three-fold increase between 2018 and 2023 in the rate of congenital syphilis, when syphilis is passed to babies during pregnancy or at birth.Footnote 78Footnote 79Footnote 80 The rate of reported cases declined in 2023, but more data are needed to determine whether this will be a persisting trend.Footnote 81
Figure 3: Text description
The figure contains four line graphs showing reported rates of infectious syphilis, congenital syphilis, chlamydia, and gonorrhea in Canada from 1996 to 2023. The horizontal axes show year. Rates for infectious syphilis, chlamydia, and gonorrhea are shown per 100,000 population; the congenital syphilis rate is shown per 100,000 live births. The four graphs use different vertical-axis scales.
| Year | Reported rate per 100,000 population |
|---|---|
| 1996 | 0.4 |
| 1997 | 0.4 |
| 1998 | 0.6 |
| 1999 | 0.6 |
| 2000 | 0.6 |
| 2001 | 0.9 |
| 2002 | 1.5 |
| 2003 | 2.9 |
| 2004 | 3.6 |
| 2005 | 3.4 |
| 2006 | 4.1 |
| 2007 | 3.8 |
| 2008 | 4.2 |
| 2009 | 4.7 |
| 2010 | 5.0 |
| 2011 | 5.1 |
| 2012 | 5.9 |
| 2013 | 6.3 |
| 2014 | 6.8 |
| 2015 | 9.0 |
| 2016 | 10.7 |
| 2017 | 11.2 |
| 2018 | 17.3 |
| 2019 | 24.5 |
| 2020 | 25.0 |
| 2021 | 32.5 |
| 2022 | 36.5 |
| 2023 | 30.5 |
| Year | Reported rate per 100,000 live births |
|---|---|
| 1996 | 0.27 |
| 1997 | 0.86 |
| 1998 | 0.29 |
| 1999 | 0.30 |
| 2000 | 0.61 |
| 2001 | 0.30 |
| 2002 | 1.21 |
| 2003 | 0.59 |
| 2004 | 0.29 |
| 2005 | 2.61 |
| 2006 | 1.68 |
| 2007 | 1.89 |
| 2008 | 1.31 |
| 2009 | 2.60 |
| 2010 | 1.32 |
| 2011 | 1.32 |
| 2012 | 0.78 |
| 2013 | 0.26 |
| 2014 | 0.26 |
| 2015 | 1.31 |
| 2016 | 1.04 |
| 2017 | 2.12 |
| 2018 | 4.50 |
| 2019 | 14.20 |
| 2020 | 14.10 |
| 2021 | 29.40 |
| 2022 | 32.70 |
| 2023 | 14.50 |
| Year | Reported rate per 100,000 population |
|---|---|
| 1996 | 117.30 |
| 1997 | 116.74 |
| 1998 | 130.56 |
| 1999 | 137.95 |
| 2000 | 149.39 |
| 2001 | 161.10 |
| 2002 | 179.15 |
| 2003 | 189.71 |
| 2004 | 200.72 |
| 2005 | 205.96 |
| 2006 | 212.88 |
| 2007 | 224.81 |
| 2008 | 248.77 |
| 2009 | 259.54 |
| 2010 | 278.53 |
| 2011 | 295.27 |
| 2012 | 303.29 |
| 2013 | 300.23 |
| 2014 | 308.41 |
| 2015 | 326.14 |
| 2016 | 335.69 |
| 2017 | 345.65 |
| 2018 | 359.93 |
| 2019 | 371.03 |
| 2020 | 278.88 |
| 2021 | 273.17 |
| 2022 | 299.21 |
| 2023 | 323.39 |
| Year | Reported rate per 100,000 population |
|---|---|
| 1996 | 17.09 |
| 1997 | 14.99 |
| 1998 | 16.83 |
| 1999 | 17.68 |
| 2000 | 20.12 |
| 2001 | 21.67 |
| 2002 | 23.02 |
| 2003 | 24.54 |
| 2004 | 27.43 |
| 2005 | 28.44 |
| 2006 | 34.69 |
| 2007 | 36.10 |
| 2008 | 38.00 |
| 2009 | 33.17 |
| 2010 | 33.47 |
| 2011 | 34.89 |
| 2012 | 37.53 |
| 2013 | 40.56 |
| 2014 | 45.90 |
| 2015 | 55.50 |
| 2016 | 65.65 |
| 2017 | 79.42 |
| 2018 | 93.65 |
| 2019 | 94.31 |
| 2020 | 81.13 |
| 2021 | 84.21 |
| 2022 | 92.36 |
| 2023 | 104.95 |
Notes:
Infectious syphilis
Infectious syphilis includes primary, secondary, early latent, and infectious neurosyphilis (<1 year after infection) stages of infection. Data were collected through routine (1996 to 2017) and enhanced (from 2018 onwards) surveillance systems. For 2023, data were received from 12 of 13 jurisdictions; Alberta estimates were projected from partial-year data. Data for 2023 are preliminary.
Congenital syphilis
Data include reported confirmed early congenital syphilis cases (diagnosed within two years of birth) based on the national case definition in effect until December 31, 2023. Data were collected through routine (1996 to 2017) and enhanced (from 2018 onwards) surveillance systems. Quebec data from 2013 to 2016 may include probable cases.
Chlamydia
Data from Nunavut are only included from 2000 onwards.
Chlamydia remains the most commonly reported sexually transmitted infection, with rates generally rising over the past three decades.Footnote 81 Although reported rates dipped in 2020 and 2021, likely due to COVID-19-related disruptions to testing, recent patterns suggest cases are increasing again.Footnote 81 The rate of reported gonorrhea cases also increased rapidly prior to the COVID-19 pandemic and was three times higher in 2023 than in 2010.Footnote 81
Some STBBI trends are encouraging. Reported hepatitis B rates have remained low, and reported hepatitis C rates have declined since reaching a recent peak in 2018.Footnote 81 Other trends are more nuanced. For example, the rate of new HIV diagnoses was relatively stable in Canada between 2012 and 2019. Following a substantial decline in 2020, likely due to reduced access to testing services, rates increased each year from 2021 to 2023 before decreasing slightly in 2024.Footnote 84Footnote 85 This recent decrease should be interpreted cautiously, as it is too early to determine whether it reflects a sustained downward trend, and the rates observed in 2023 and 2024 were higher than at any point in the previous decade.Footnote 85Footnote 86 Certain populations also continue to be disproportionately affected.Footnote 85Footnote 87 Within national trends there is great variability across geographic regions and communities, with some reporting rates of certain STBBIs that are much lower or higher than the national average.Footnote 86Footnote 88
Why does this matter?
Communities, researchers, and governments have worked collaboratively on improving the prevention, diagnosis, and treatment of STBBIs. This has also included efforts to reduce stigma and raise the quality of life for people living with or affected by these infections.Footnote 89 Yet the health impacts of STBBIs can be significant. For example, congenital syphilis can have serious consequences including stillbirth and infant death.Footnote 78Footnote 79 There are also implications for treatment. For instance, more gonorrhea cases are being detected in which the bacteria have developed resistance to one or more of the drugs used to treat the infection.Footnote 90
Higher rates of STBBIs among certain groups reflect the influence of broader forces, like colonialism and discrimination, as well as inequities in conditions such as income, housing, food security, and access to health and social services.Footnote 91Footnote 92 Many complex and interconnected factors intersect to both increase exposure to STBBIs and create barriers to STBBI prevention, testing, and treatment for some people.Footnote 91 Rising STBBI rates and persisting inequities underscore the need for timely, high-quality data and coordinated responses across sectors that respond to the realities and needs of affected populations.Footnote 91Footnote 93Footnote 94
Measles outbreak highlights the importance of vaccination
What is changing?
Since the introduction of routine 2-dose vaccination programs in 1996 to 1997, measles has been rare in Canada.Footnote 95Footnote 96 Between 1998 and 2024, there were an average of 91 cases reported annually, predominantly associated with infections imported through international travel from areas where measles is endemic, with limited subsequent spread within Canada.Footnote 95Footnote 97Footnote 98
Against the backdrop of a global resurgence of measles, a large multijurisdictional outbreak began in late 2024.Footnote 97Footnote 99 In 2025, Canada lost measles elimination status as a result of more than a year of sustained transmission of the same measles virus strain.Footnote 100 There were a total of 5,462 measles cases reported in 2025, with most linked to this multijurisdictional outbreak (Figure 4).Footnote 97 Spread slowed significantly in 2026 and in October the outbreak was declared over.Footnote 97
Figure 4: Text description
The figure is a bar graph showing the annual number of measles cases in Canada from 1998 to 2025. The horizontal axis shows year and the vertical axis shows the number of cases. Confirmed cases are shown for all years; probable cases are also included for 2025.
| Year | Number of confirmed cases | Number of probable cases |
|---|---|---|
| 1998 | 17 | N/A |
| 1999 | 32 | N/A |
| 2000 | 207 | N/A |
| 2001 | 38 | N/A |
| 2002 | 9 | N/A |
| 2003 | 17 | N/A |
| 2004 | 9 | N/A |
| 2005 | 8 | N/A |
| 2006 | 13 | N/A |
| 2007 | 101 | N/A |
| 2008 | 61 | N/A |
| 2009 | 14 | N/A |
| 2010 | 99 | N/A |
| 2011 | 752 | N/A |
| 2012 | 10 | N/A |
| 2013 | 83 | N/A |
| 2014 | 418 | N/A |
| 2015 | 196 | N/A |
| 2016 | 11 | N/A |
| 2017 | 45 | N/A |
| 2018 | 29 | N/A |
| 2019 | 113 | N/A |
| 2020 | 1 | N/A |
| 2021 | 0 | N/A |
| 2022 | 3 | N/A |
| 2023 | 12 | N/A |
| 2024 | 146 | N/A |
| 2025 | 5,085 | 377 |
Notes: Cases are plotted based on year of rash onset. Probable cases are only included for 2025. They are excluded in previous years as they are not systematically reported to the Canadian Measles and Rubella Surveillance System.
The initial case leading to this outbreak was linked to exposure outside Canada, but then spread continued in Canada, mainly in under-vaccinated communities.Footnote 95Footnote 98 Within the outbreak, 94% of cases were in unvaccinated people or those with unknown vaccination status.Footnote 97
Why does this matter?
Measles is a highly contagious infectious disease that can have severe health consequences.Footnote 96 Since Canada achieved measles elimination status in 1998, high overall vaccination coverage combined with public health responses to the small number of imported cases limited measles transmission.Footnote 95 Global measles outbreaks and the resumption of international travel after the COVID-19 pandemic subsequently highlighted significant immunity gaps in under-vaccinated communities in Canada.Footnote 95
Maintaining continued high vaccination coverage is needed to protect Canada's population as a whole, including infants too young to be vaccinated, pregnant people, individuals who cannot be vaccinated for medical reasons, or others who have limited immune protection. The resurgence of measles highlights the importance of addressing disparities in vaccination coverage. Overall vaccination coverage estimates may not fully capture how immunity is distributed geographically or within communities. While achieving and maintaining high vaccination coverage at a population level is essential, clusters of under-vaccinated individuals can increase the risk of localized outbreaks.Footnote 102Footnote 103
In some provinces and territories, there appears to have been a decrease in measles vaccination coverage among children aged two and seven years from 2019 to 2023 (Figure 5).Footnote 104Footnote 105Footnote 106 In 2024/2025, this decline appears to have stabilized, but coverage has not recovered.Footnote 105 Vaccine uptake can be driven by a variety of factors including ease of access to vaccines, the level of concern about vaccine-preventable diseases, and vaccine confidence.Footnote 107Footnote 108 Some populations face greater structural barriers to vaccine access, which could include competing pressures on resources to book vaccine appointments or travel to clinics.Footnote 109Footnote 110 Facilitating vaccine uptake is critical to strengthen protection against measles and enhance preparedness for future infectious disease threats.Footnote 109
Figure 5: Text description
The figure is a line graph showing measles vaccination coverage among children aged 2 years and 7 years in selected provinces and territories from 2019 to 2025. The horizontal axis shows year and the vertical axis shows measles vaccination coverage as a percentage. One line represents children aged 2 years who had received one or more doses, and a second line represents children aged 7 years who had received two or more doses.
| Year | Age 2: one or more doses (%) | Age 7: two or more doses (%) |
|---|---|---|
| 2019 | 88.9 | 85.4 |
| 2020 | 87.9 | 81.1 |
| 2021 | 84.8 | 79.0 |
| 2022 | 81.3 | 77.8 |
| 2023 | 84.6 | 75.0 |
| 2024 | 80.2 | 74.2 |
| 2025 | 79.7 | 76.5 |
Notes: Figure shows measles vaccination coverage in provinces and territories reporting to the Standardized Reporting on Vaccination (STARVAX) surveillance system. For those aged two years this is one or more dose of a vaccine against measles and for those aged seven years this is two or more doses of a vaccine against measles. Reference date is December 31 of each year. Only provinces and territories that reported for all years from 2019 to 2025 are included. For two-year-olds this includes Alberta, Saskatchewan, Manitoba, New Brunswick, and Yukon and for seven-year-olds this includes Alberta, Saskatchewan, Manitoba, and Yukon.
Cancer outcomes are improving overall, but population health impacts remain high and some patterns are shifting
What is changing?
Over the past several decades, there have been promising trends in overall cancer cases and deaths in Canada. As of 2021, the rate of new cancer cases, adjusted for age, had decreased by 1.2% annually since 2011 for males and 0.4% annually since 2012 for females (Figure 6).Footnote 111 Since peaking in the late 1980s for males and mid 1990s for females, overall cancer death rates have declined significantly, by 42% in males and 28% in females (Figure 6).Footnote 111 These declines are evident across several of the most common cancer types, including lung cancer, likely driven by long-term reductions in tobacco use, and colorectal cancer, in part due to screening programs.Footnote 111
Figure 6: Text description
The figure is a line graph showing age-standardized cancer incidence and mortality rates in Canada from 1984 to 2025. The horizontal axis shows year and the vertical axis shows the rate per 100,000 population. Six lines show incidence and mortality for both sexes combined, males, and females. The shaded area on the right side of the graph represents projected rates, from 2020 to 2025 for incidence and 2023 to 2025 for mortality.
| Year (selected time points) | Incidence: both sexes | Incidence: males | Incidence: females | Mortality: both sexes | Mortality: males | Mortality: females |
|---|---|---|---|---|---|---|
| 1984 | 566.38 | 700.24 | 478.09 | 300.77 | 395.65 | 235.16 |
| 1993 | 622.75 | 790.68 | 507.36 | 301.00 | 391.36 | 240.88 |
| 2001 | 614.69 | 753.04 | 515.99 | 285.89 | 367.01 | 232.77 |
| 2003 | 602.00 | 722.70 | 516.23 | 280.96 | 352.66 | 233.95 |
| 2005 | 610.39 | 726.76 | 525.71 | 272.48 | 340.01 | 227.11 |
| 2007 | 618.91 | 733.34 | 533.55 | 266.57 | 328.70 | 224.04 |
| 2009 | 608.51 | 706.72 | 535.63 | 257.84 | 317.65 | 217.08 |
| 2011 | 653.45 | 764.91 | 569.80 | 249.70 | 304.53 | 212.18 |
| 2013 | 613.68 | 692.11 | 556.59 | 244.07 | 294.49 | 208.92 |
| 2015 | 610.77 | 683.50 | 556.86 | 237.93 | 284.79 | 204.98 |
| 2017 | 608.92 | 681.12 | 553.87 | 233.63 | 279.34 | 200.49 |
| 2019 | 602.62 | 665.55 | 555.54 | 221.83 | 267.51 | 188.41 |
| 2020 | 606.49 | 672.50 | 556.31 | 218.46 | 260.51 | 188.08 |
| 2021 | 605.76 | 670.34 | 556.61 | 216.75 | 257.74 | 186.63 |
| 2022 | 605.15 | 668.58 | 556.80 | 209.53 | 246.91 | 182.07 |
| 2023 | 604.54 | 666.79 | 557.12 | 208.51 | 247.48 | 179.38 |
| 2024 | 604.11 | 665.25 | 557.23 | 205.57 | 243.56 | 176.75 |
| 2025 | 603.48 | 663.57 | 557.39 | 202.57 | 239.57 | 174.33 |
Notes: Figure adapted from Canadian Cancer Statistics 2025, which provides details of the estimation methods. Incidence and mortality rates are age-standardized to the 2021 Canadian standard population.
Cancer remains a complex and evolving group of more than 100 diseases, and trends have not been the same across all types. For example, continuing increases in incidence are projected for melanoma, uterine, and pancreatic cancers.Footnote 112 Cervical cancer incidence has stopped declining after many years of progress.Footnote 111Footnote 112Footnote 113 Rates of certain types of cancer, such as breast and colorectal, appear to be rising among younger people in Canada and other comparable countries.Footnote 114Footnote 115Footnote 116Footnote 117
Why does this matter?
Emerging trends, such as cervical cancer rates no longer declining and increasing rates of some cancers among younger people, warrant continued monitoring and further research to better understand how and why cancer patterns may be evolving.Footnote 111Footnote 112 In this context, population-level cancer prevention measures, such as increasing HPV vaccination access and uptake, remain important.Footnote 111 Evidence from Canada and other countries shows the profound impact that combining effective and widespread vaccination and cervical screening programs can have on moving toward cervical cancer elimination.Footnote 118Footnote 119Footnote 120
Additionally, inequities in cancer incidence, mortality, and survival persist, shaped by differences in exposure to risk factors and access to screening and timely care.Footnote 111Footnote 121 Inequities can occur due to many social factors, such as income or education. They can also be underpinned by broader forces, including discrimination and stigma, that create barriers for some groups across cancer prevention, early detection, diagnosis, and treatment.Footnote 111Footnote 121 These determinants intersect in complex ways to influence who develops cancer, the types of cancer they develop, and their chances of survival.Footnote 121
Observed progress across several cancer outcomes reflects sustained advances in prevention, early detection, and treatment.Footnote 111Footnote 112 However, cancer remains the leading cause of death in Canada, and it is estimated that about two in five people will be diagnosed with cancer in their lifetime.Footnote 111Footnote 122Footnote 123 Additionally, the total number of new cases and deaths attributed to cancer each year are expected to remain high. This trend is largely driven by Canada's aging population, as the risk of developing many cancers increases with age.Footnote 111 By 2068, more than one in four people in Canada are expected to be aged 65 years or older, and the number of people aged 85 years or older is projected to more than triple.Footnote 124 As a result, the overall impact of cancer on individuals, communities, and health systems is expected to remain substantial even as outcomes improve.
Wildfires are increasing in size and intensity, with wide-ranging impacts on health
What is changing?
Climate change is driving rapid changes in wildfire patterns across Canada.Footnote 125Footnote 126Footnote 127 Fire is a natural and essential part of forests in Canada. However, wildfire seasons are lengthening, and wildfires are growing larger and more destructive, increasingly disrupting people's daily lives and livelihoods, including in new or historically lower risk areas.Footnote 128Footnote 129Footnote 130 Urban and industrial development is also expanding into wildlands, increasing the number of wildfires that happen where wildland vegetation and the built environment meet or mix.Footnote 131
As a result of these developments, more people living in Canada are being exposed to the health, social, and economic impacts of wildfires and wildfire smoke. This includes people who are forced to evacuate, sometimes for weeks or months at a time.Footnote 132Footnote 133Footnote 134 Data collection on the annual number of evacuees began in 1980, but seven of the 10 worst years occurred in the past decade.Footnote 135
Why does this matter?
Wildfires can create various immediate and long-term health risks for local populations and wildland firefighters. They also more broadly affect the well-being of communities, including through the destruction of homes, businesses, and infrastructure. Evacuating due to wildfires can affect people's health in many ways. For instance, it can negatively impact mental health, disrupt social and community support, interrupt access to necessary health care, and lead to lost income from missed work.Footnote 136Footnote 137Footnote 138Footnote 139Footnote 140 These effects can be long-lasting, emphasizing the importance of long-term community support during recovery.Footnote 141
Wildfires and wildfire evacuations have disproportionate impacts on Indigenous communities.Footnote 142 Between 1980 and 2021, 41.9% of wildfire evacuations involved communities with predominantly Indigenous populations.Footnote 134 Evacuations can have unique consequences for Indigenous Peoples, including the effects of prolonged separation from community, family, and land-based cultural practices as well as a lack of culturally safe care in host communities.Footnote 136Footnote 138Footnote 143Footnote 144Footnote 145 Since Indigenous Peoples maintain deep cultural, spiritual, and livelihood connections to their lands, the impacts of displacement can be broad, complex, and long-lasting.Footnote 138Footnote 143
First Nations, Inuit, and Métis Peoples have supported the natural rhythm of ecosystems since time immemorial by stewarding the lands, waters, and ecosystems through diverse systems of knowledge, governance, and reciprocal relationships with the natural world. This place-based stewardship includes the intentional application of fire on the landscape (beneficial fire, or cultural burning) to sustain ecosystem health, enhance biodiversity, reduce wildfire risk, support culturally important species and landscapes, strengthen community resilience, and uphold cultural practices, languages, and knowledge transfer to future generations.Footnote 146Footnote 147Footnote 148
The effects of wildfire smoke can extend far beyond local communities, with the potential to affect people who live hundreds or even thousands of kilometres away. Pollutants from wildfire smoke exposure have been associated with a number of adverse health outcomes, including increased risk of premature mortality, as well as respiratory, cardiovascular, and developmental effects.Footnote 149 Additionally, wildfire smoke may be associated with neurological effects, cancer, and skin and eye conditions.Footnote 149 Research has identified greater impacts of wildfire smoke for some groups, including children and older adults, people who are pregnant, people who are unhoused, people living with chronic illness, and people who work outdoors.Footnote 132Footnote 133Footnote 136Footnote 150 These differences can be due to higher exposure, greater susceptibility to negative health outcomes, and inequitable access to the resources that help people protect themselves.Footnote 139Footnote 140Footnote 149Footnote 151
Looking forward
Across the trends examined in this report, the following three themes stand out:
- Some health outcomes among younger populations are changing in ways that may have important implications for future population health.
- Many of the challenges highlighted reinforce the value of prevention and preparedness.
- Responding effectively to emerging and evolving health issues depends on strong evidence, trusted institutions, and effective public health leadership.
Together, these point to overarching priority areas for the CPHO's mandate. Across each of these, advancing health equity and supporting reconciliation remain essential. Persistent inequities continue to shape who experiences risks and who benefits from opportunities to be healthy. Social, economic, geographic, and demographic factors intersect and compound over time to drive these differences in many interconnected health outcomes. Public health systems play an important role in drawing attention to the social and structural determinants that shape health, and working with partners across sectors to address the conditions that create inequities.
Public health professionals also have a responsibility to advance reconciliation and uphold Indigenous rights and self-determination. This includes strengthening partnerships with First Nations, Inuit, and Métis Peoples, furthering culturally safe and responsive approaches, advocating for Indigenous Knowledges to be incorporated into evidence systems, and supporting Indigenous-led priorities that promote health and well-being.
Supporting the health and well-being of younger populations
The experiences and health of young people today will shape population health for decades to come. Patterns across several topics in this report suggest that some health outcomes among younger populations are changing, including mental health, health-adjusted life expectancy, sexually transmitted and blood-borne infections, and some types of cancer. These outcomes do not affect all younger people the same way and vary across diverse social and economic contexts.
Responding to these trends requires a life course approach that promotes health and well-being throughout all stages of life. This perspective helps identify opportunities to improve outcomes and reduce inequities by recognizing how health is shaped by the cumulative impact of experiences, environments, and opportunities. Mental health promotion can complement this approach by emphasizing action at individual, community, and societal levels to strengthen protective factors and create conditions that support lifelong well-being.
Given the complexity of the world today, we must continue efforts to better understand drivers of health outcomes, including how a rapidly changing climate and evolving social and digital environments affect health. Building this evidence base will be critical for identifying the most effective ways to support young people.
Strengthening prevention and preparedness
The resurgence of measles, worsening mental health outcomes, the ongoing toxic drug crisis, and the growing impacts of wildfires serve as reminders that public health systems must prioritize both prevention and preparedness. Prevention focuses on addressing risks before health problems occur, while preparedness is about being ready to respond to new and emerging threats when they arise.
The greatest benefits of prevention come from creating a foundation of health-promoting behaviours and environments across the population. This includes reducing exposure to risks and ensuring everyone has access to resources that help them stay healthy.
To be prepared, public health systems must be able to anticipate, adapt to, and recover from evolving threats, including the growing impacts of climate-related events, misinformation and disinformation, and changing geopolitical contexts. This includes maintaining a skilled, supported, and diverse workforce, strengthening collaboration and governance across jurisdictions, and ensuring that public health organizations can respond effectively to emerging risks and new evidence.
Initiatives that support vaccination are key examples of preventative efforts. The recent measles outbreak is a cautionary signal that progress in reducing vaccine-preventable diseases cannot be assumed to be permanent. Public health systems can learn from this experience to strengthen preparedness for future diseases that may emerge or re-emerge in the years ahead.
Building knowledge, trust, and public health leadership
Public health organizations need strong, interconnected research, data, and evidence systems to understand emerging health challenges and guide actions. This includes generating knowledge through interdisciplinary, community-based, and Indigenous approaches that bring together diverse ways of knowing.
For example, there is a growing need to better understand how information systems, artificial intelligence, and online environments shape health and well-being, as well as the opportunities and risks they present. Continued research can inform policies, programs, and communications that help people navigate and thrive in increasingly complex digital spaces. Successfully applying these insights will depend on evidence-informed guidance and appropriate governance and infrastructure. This work should also be grounded in equity while engaging young people as partners in shaping solutions, and bringing their perspectives and lived experiences into the decisions that affect them.
Building an understanding of how information shapes health is also critical to fostering trust. Public health institutions can earn trust through demonstrating how evidence is used to make decisions, learning from and partnering with communities, and communicating in ways that are clear, timely, and responsive to people's concerns.
New pressures and rapidly changing environments necessitate strong public health leadership at all levels. This leadership is critical for meaningful collaboration with communities, translating evidence into action, and fostering the partnerships that are essential to support population health and well-being. People and relationships are the foundation of public health systems, and a strong public health workforce is essential to protecting and promoting health.
Methodology
The development of this report involved identifying, appraising, and synthesizing the best available evidence on select public health topics. This included surveillance, survey, and administrative data from public health and other key government partners, academic and community-based research, and input from internal public health and government experts. Canadian research and representative data were prioritized.
Topic selection
- The 2026 report presented an opportunity to reflect on population health at the beginning of the CPHO's mandate. A range of public health topics were assessed that had notable recent developments.
- Multiple criteria were used to select topics for inclusion, including the availability of Canadian evidence, whether recent developments made the issue timely for inclusion, and whether the topic could be meaningfully examined in the context of a national trends-focused report.
Indicator data
- Key data on each topic were identified, with a focus on recent, relevant, and high-quality national outcome data. To identify emerging and urgent issues, there was also a focus on data availability over time to allow for an analysis of trends. Where possible and relevant, disaggregated data was included.
- Public health data sources included population health surveys, surveillance data, and health system outcome and administrative data.
- Data from other government sources included vital statistics, census data, and specialized databases (e.g., Canadian Wildland Fire Evacuation Database).
Evidence reviews
- Targeted academic literature searches were completed by the Office of the Chief Public Health Officer for each public health topic, using online databases, such as MEDLINE and Scopus. Grey literature searches were also completed for government publications, public health agency reports, and reports from national and international organizations. Canadian research was prioritized.
- Research questions for these searches were focused on understanding the context, drivers, and public health impact for each selected public health topic, as well as key equity considerations.
Engagement and feedback process
- Report drafts were submitted for internal review across the Public Health Agency of Canada as well as to experts in other government departments. An iterative feedback process was used to help identify and prioritize indicators, ensure use of the most relevant and recent data, interpret data trends, explore drivers and determinants, and understand context for each public health topic.
- Report drafts were also shared with external First Nations, Inuit, and Métis organizations and the National Collaborating Centres for Public Health.
Limitations
- Data and evidence availability vary across topic areas.
- Data limitations include availability and timeliness, variability in data collection and reporting across the country, challenges with surveys using self-report methods, underrepresentation of some populations, and limited opportunities for disaggregation.
- Indicator data explores how things are changing over time but cannot explain why these changes are occurring. Where possible, based on research availability and the scope of the report, brief additional information is provided to explore the factors that influence health outcomes. Understanding the factors that drive trends and inequities in population health requires disaggregated data, community knowledge, and a focus on determinants.
- The report focused on a small subset of public health topics and does not represent all important dimensions of population health.
Inclusive language
- Wherever possible, the report focuses on inclusive and culturally appropriate language related to each public health topic. However, as a report focused on indicator data, epidemiological terms are often used (e.g., male and female) as reflected in the original source, rather than more inclusive language that represents the diversity and complexity of identity, health, and well-being.
Acknowledgements
I want to acknowledge the guidance and substantial contributions provided by Dr. Natasha Crowcroft while serving as interim Chief Public Health Officer.
The report benefited significantly from the expertise and collaborative efforts of colleagues at the Public Health Agency of Canada, and other departments across the Government of Canada, including Health Canada, Crown-Indigenous Relations and Northern Affairs Canada, Indigenous Services Canada, Natural Resources Canada, and Statistics Canada. I would like to sincerely thank them for their insights and thoughtful reviews of report drafts.
I am grateful to external reviewers and organizations for reviewing the report, including the Assembly of First Nations, the National Collaborating Centres for Public Health, the Canadian Cancer Society, and Dr. Cory Neudorf, Professor of Community Health and Epidemiology at the University of Saskatchewan.
Finally, I would like to recognize my colleagues in the Office of the Chief Public Health Officer for their teamwork and contributions to this report. Special thanks to the Reports Team: Fabienne Boursiquot, Dr. Marie Chia, Dr. Charlene Cook, Elyse Fortier, Dr. Kimberly Gray, Jennifer Lew, Sarah Maxwell, and Dr. Sarah Schwarz.
References
- Footnote 1
-
Gilbert, R, Cliffe, SJ. Public Health Surveillance. Public Health Intelligence. 2016:91–110.
- Footnote 2
-
Choi, BCK. The Past, Present, and Future of Public Health Surveillance. Scientifica. 2012; 2012(1):875253.
- Footnote 3
-
Shah, HA, Househ, M. Purpose-Oriented Review of Public Health Surveillance Systems: Use of Surveillance Systems and Recent Advances. BMJ Public Health. 2024; 2(1):e000374.
- Footnote 4
-
Public Health Agency of Canada. A Vision for Public Health Surveillance in Canada by 2030: Technical Discussion Guide. 2023.
- Footnote 5
-
Statistics Canada. Life Expectancy and Other Elements of the Complete Life Table, Single-Year Estimates, Canada, All Provinces except Prince Edward Island. 2026. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=1310083701.
- Footnote 6
-
Statistics Canada. Description for Chart 1 Total Number of Expected Years of Life at Birth and at Age 90, 1921-2011. 2015. Available from: https://www150.statcan.gc.ca/n1/pub/82-624-x/2014001/article/14009/c-g/desc/desc-01-eng.htm.
- Footnote 7
-
Lang, J, George, D, Orpana, H. Declines in Life Expectancy at Birth in Canada Due to Accidental Drug-Related Poisoning Deaths, 2000 to 2021. [Internal]. 2026.
- Footnote 8
-
Statistics Canada. Key Findings from the Health of Canadians Report, 2024. The Daily; 2025. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/250305/dq250305a-eng.htm.
- Footnote 9
-
Statistics Canada. Deaths, 2020. The Daily; 2022. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/220124/dq220124a-eng.htm.
- Footnote 10
-
Choquette, J, Ouellette, N. Contribution de la mortalité adulte à l’érosion des gains d’espérance de vie dans les provinces canadiennes. Cahiers québécois de démographie. 2026. (in French only)
- Footnote 11
-
Statistics Canada. Deaths, 2024. The Daily; 2026. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/260113/dq260113b-eng.htm.
- Footnote 12
-
Statistics Canada. Table: 13-10-0971-01 Health-Adjusted Life Expectancy, by Sex and Income Quintile. Government of Canada; 2026. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310097101.
- Footnote 13
-
Statistics Canada. Chart 1 Health-Adjusted Life Expectancy (HALE) at Birth and Age 65 Years, Both Sexes, Canada, 2000 to 2023. The Daily; 2026. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/260109/cg-b001-eng.htm.
- Footnote 14
-
Saito, Y, Robine, JM, Crimmins, EM. The Methods and Materials of Health Expectancy. Statistical Journal of the IAOS. 2014; 30(3):209–23.
- Footnote 15
-
Statistics Canada. Health-Adjusted Life Expectancy in Canada: Recent Trends at Birth and Age 65 Years, 2019, 2020 and 2023. The Daily; 2026. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/260109/dq260109b-eng.htm.
- Footnote 16
-
Statistics Canada. Functional Health of Canadian Adults, 2015 to 2024. The Daily; 2026. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/260316/dq260316d-eng.htm?utm_source=mstatcan&utm_medium=eml&utm_campaign=statcan-statcan-mstatcan.
- Footnote 17
-
Public Health Agency of Canada. Key Health Inequalities in Canada: A National Portrait. 2018.
- Footnote 18
-
Statistics Canada. Life Expectancy at Birth and Infant Mortality Rates of Indigenous Populations in Canada. The Daily; 2025. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/250603/dq250603b-eng.htm.
- Footnote 19
-
Tjepkema, MB, Bushnik, T, Bougie, E. Life Expectancy of First Nations, Métis and Inuit Household Populations in Canada. Statistics Canada Health Reports. 2019; 30(12):3–10.
- Footnote 20
-
Dion, P, Tremblay, MA, Gagnon, R, Sirag, E. Life Expectancy at Birth and Infant Mortality Rates of Indigenous Populations in Canada from 2004 to 2016. Canadian Studies in Population. 2024; 51(2):3.
- Footnote 21
-
Statistics Canada. Table: 17-10-0160-01 Life Expectancy at Birth of Indigenous Populations in Canada. Government of Canada; 2025. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710016001&request_locale=en.
- Footnote 22
-
Public Health Agency of Canada. How Healthy Are People in Canada? An Indicators Dashboard. 2025.
- Footnote 23
-
Statistics Canada. Table: 13-10-0096-01 Health Characteristics, Annual Estimates, Inactive. Government of Canada; 2023. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/cv!recreate.action?pid=1310009601&selectedNodeIds=2D2,4D3,5D4,5D5,5D6&checkedLevels=0D1,2D2&refPeriods=20150101,20220101&dimensionLayouts=layout2,layout2,layout3,layout3,layout2,layout3&vectorDisplay=false.
- Footnote 24
-
Health Infobase. Data Tool: Mental Health of Youth and Young Adults. Government of Canada; 2025. Available from: https://health-infobase.canada.ca/mental-health/youth-young-adults/data-tool.html.
- Footnote 25
-
Statistics Canada. Table: 13-10-0905-01 Health Indicator Statistics, Annual Estimates. Government of Canada; 2025. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310090501.
- Footnote 26
-
Statistics Canada. Table: 13-10-0948-01 Health Indicator Statistics for Youth Aged 12 to 17 Years, Youth Reported. Government of Canada; 2025. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310094801.
- Footnote 27
-
Stephenson, E. Mental Disorders and Access to Mental Health Care. Statistics Canada; 2023. Available from: https://www150.statcan.gc.ca/n1/pub/75-006-x/2023001/article/00011-eng.htm.
- Footnote 28
-
Health Infobase. Positive Mental Health Surveillance Indicator Framework. Government of Canada; 2024. Available from: https://health-infobase.canada.ca/positive-mental-health/.
- Footnote 29
-
Organisation for Economic Co-operation and Development (OECD). How to Make Societies Thrive? Coordinating Approaches to Promote Well-Being and Mental Health. 2023.
- Footnote 30
-
Public Health Agency of Canada. Working Together to Thrive: Well-Being and Public Health. Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2025. 2025.
- Footnote 31
-
Chiu, M, Amartey, A, Wang, X, Vigod, S, Kurdyak, P. Trends in Objectively Measured and Perceived Mental Health and Use of Mental Health Services: A Population-Based Study in Ontario, 2002-2014. CMAJ. 2020; 192(13):E329–E37.
- Footnote 32
-
Rubin-Kahana, DS, Nevo, GA, Boileau, I. Are the Kids Alright? Making Sense of the Current Youth Mental Health Crisis in Canada through Heuristics and Data. Journal of Psychiatry and Neuroscience. 2025; 50(4):E267–E74.
- Footnote 33
-
Organisation for Economic Co-operation and Development (OECD). The Economic Case for Preventing Mental Ill Health. 2026.
- Footnote 34
-
Foulkes, L, Andrews, JL. Are Mental Health Awareness Efforts Contributing to the Rise in Reported Mental Health Problems? A Call to Test the Prevalence Inflation Hypothesis. New Ideas in Psychology. 2023; 69:101010.
- Footnote 35
-
McGorry, P, Gunasiri, H, Mei, C, Rice, S, Gao, CX. The Youth Mental Health Crisis: Analysis and Solutions. Frontiers in Psychiatry. 2025; 15.
- Footnote 36
-
McGorry, PD, Mei, C, Dalal, N, Alvarez-Jimenez, M, Blakemore, SJ, Browne, V, et al. The Lancet Psychiatry Commission on Youth Mental Health. Lancet Psychiatry. 2024; 11(9):731–74.
- Footnote 37
-
Blanchflower, D, Bryson, A, Xu, X. The Declining Mental Health of the Young and the Global Disappearance of the Unhappiness Hump Shape in Age. PLOS ONE. 2025; 20(8):e0327858.
- Footnote 38
-
Organisation for Economic Co-operation and Development (OECD). Child, Adolescent and Youth Mental Health in the 21st Century. Paris: 2026.
- Footnote 39
-
Shiraz, M, Capaldi, C, Ooi, L, Roberts, K. Original Quantitative Research – Health Care Barriers and Perceived Mental Health among Adults in Canada during the COVID-19 Pandemic: A Population-Based Cross-Sectional Study. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice. 2024; 44(1).
- Footnote 40
-
World Health Organization, Calouste Gulbenkian Foundation. Social Determinants of Mental Health. Geneva: 2014.
- Footnote 41
-
Statistics Canada. Health Care Access and Experiences among Indigenous People, 2024. The Daily; 2024. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/241104/dq241104a-eng.htm.
- Footnote 42
-
Public Health Agency of Canada. Inequalities in Mental Health, Well-Being and Wellness in Canada. 2024.
- Footnote 43
-
Kirkbride, JB, Anglin, DM, Colman, I, Dykxhoorn, J, Jones, PB, Patalay, P, et al. The Social Determinants of Mental Health and Disorder: Evidence, Prevention and Recommendations. World Psychiatry. 2024; 23(1):58–90.
- Footnote 44
-
Health Canada, Assembly of First Nations. First Nations Mental Wellness Continuum Framework - Summary Report. 2014.
- Footnote 45
-
Indigenous Primary Health Care Council. A Wholistic and Strength-Based Approach for Measuring Health and Wellness: Considerations for Public Health Indicators. 2025.
- Footnote 46
-
Health Infobase. Key Findings: Opioid- and Stimulant-Related Harms in Canada. Government of Canada; 2026. Available from: https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/.
- Footnote 47
-
Health Canada. New and Emerging Drug Threats in Canada: Fentanyl Precursors. 2025.
- Footnote 48
-
Health Infobase. Graphs: Opioid- and Stimulant-Related Harms in Canada. Government of Canada; 2026. Available from: https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/graphs.html?ind=11&unit=0.
- Footnote 49
-
Health Infobase. Decline in Opioid-Related Deaths in Canada. Government of Canada; 2025. Available from: https://health-infobase.canada.ca/substances/harms/decline-opioid-related-deaths/#drug-supply.
- Footnote 50
-
Toward the Heart; BCCDC Harm Reduction Services. Unregulated Drug Supply Substance Information Sheet. 2024. Available from: https://towardtheheart.com/assets/uploads/1782323341PqsYt9mhJqBzlcdPSQh2OKY0urR05mCQSsAkBRM.pdf
- Footnote 51
-
Northwestern Health Unit. Drug Alert Medetomidine. 2026. Available from: https://www.nwhu.on.ca/wp-content/uploads/2026/03/Drug-Alert-Medetomidine-2026.03.27.pdf.
- Footnote 52
-
Ontario Poison Centre. Medetomidine in the Unregulated Opioid Supply: A Clinical Brief for Ontario Health Care Providers. 2026. Available from: https://www.ontariopoisoncentre.ca/siteassets/pdfs/english/patient-care-resources-documents/medetomidine-opc-clinical-brief---march-10-2026.pdf.
- Footnote 53
-
Miles, I, Koh, JJ, Bach, P. Medetomidine in the Unregulated Drug Supply. Canadian Medical Association Journal. 2026; 198(26):E1019–E20.
- Footnote 54
-
Morrow, RL, Bassett, K, Maclure, M, Dormuth, CR. Outcomes Associated with Hospital Admissions for Accidental Opioid Overdose in British Columbia: A Retrospective Cohort Study. BMJ Open. 2019; 9(5):e025567.
- Footnote 55
-
Kitchen, SA, McCormack, D, Werb, D, Caudarella, A, Martins, D, Matheson, FI, et al. Trends and Outcomes of Serious Complications Associated with Non-Fatal Opioid Overdoses in Ontario, Canada. Drug and Alcohol Dependence. 2021; 225:108830.
- Footnote 56
-
Ontario Drug Policy Research Network. Ontario Opioid Indicator Tool. Toronto, ON: 2026. Available from: https://odprn.ca/ontario-opioid-indicator-tool/.
- Footnote 57
-
Xavier, CG, Kuo, M, Desai, R, Palis, H, Regan, G, Zhao, B, et al. Association between Toxic Drug Events and Encephalopathy in British Columbia, Canada: A Cross-Sectional Analysis. Substance Abuse Treatment, Prevention, and Policy. 2023; 18(1):42.
- Footnote 58
-
The Ontario Drug Policy Research Network; Public Health Ontario. Characteristics of Substance-Related Toxicity Deaths in Ontario: Stimulant, Opioid, Benzodiazepine, and Alcohol-Related Deaths. 2023.
- Footnote 59
-
Li, Y, Pierce, DV, Vik, S, Dong, K, Patten, S, Zhang, Y, et al. Co-Involvement of Stimulants with Opioids in North America: A 'Silent Epidemic'. PLOS Mental Health. 2025; 2(7):e0000319.
- Footnote 60
-
Ledlie, S, Holton, A, Leece, P, Hamzat, B, Yang, J, Kolla, G, et al. The Changing Role of Substances: Trends, Characteristics of Individuals and Prior Healthcare Utilization among Individuals with Accidental Substance-Related Toxicity Deaths in Ontario Canada. PLOS ONE. 2025; 20(5):e0324732.
- Footnote 61
-
Health Infobase. Results: Multi-Drug Involvement in Apparent Opioid and Stimulant Toxicity Deaths in Canada from 2018 to 2023. Government of Canada. 2025. Available from: https://health-infobase.canada.ca/substance-related-harms/multi-drug-involvement/results.html.
- Footnote 62
-
Watson, TM, Chochla, S, Kim, A, MacIntosh, K, Bonn, M, Haines-Saah, R, et al. Defining a Public Health Approach to Substance Use: Perspectives from Professionals and Practitioners across Canada. International Journal of Drug Policy. 2024; 128:104427.
- Footnote 63
-
British Columbia's Office of the Human Rights Commissioner. A Human Rights-Based Approach to the Toxic Drug Crisis. 2025.
- Footnote 64
-
MacDonald, M, Cheng, C, Wang, T, McCormack, D, Kolla, G, Cahill, TM, et al. Trends in Varying Modes of Drug Use in Opioid Toxicity Deaths in Ontario from 2017 to 2021. International Journal of Drug Policy. 2025; 141:104197.
- Footnote 65
-
Xavier, JC, Burmeister, C, Henderson, I, Rufus-Sedgemore, K-O, Streukens, A, Lock, K, et al. Responding to an Evolving Crisis: Meeting the Needs of a Growing Population Who Smoke Their Unregulated Substances. Canadian Journal of Public Health. 2025; 116(4):566–72.
- Footnote 66
-
Ontario Agency for Health Protection and Promotion (Public Health Ontario); Community Opioid/ Overdose Capacity Building (COM-CAP). At a Glance: Harm Reduction Services for Anyone Who Smokes or Inhales Drugs. Toronto, ON: 2023.
- Footnote 67
-
Ledlie, S, Leece, P, Yang, J, Iacono, A, Kolla, G, Boyd, R, et al. Trends, Characteristics, and Circumstances Surrounding Stimulant Toxicity Deaths in Ontario, Canada from 2018 to 2021. Journal of Substance Use and Addiction Treatment. 2025; 170:209614.
- Footnote 68
-
Ledlie, S, Juurlink, DN, Tadrous, M, Mamdani, M, Paterson, JM, Gomes, T. Opioid-Related Deaths between 2019 and 2021 across 9 Canadian Provinces and Territories. Canadian Medical Association Journal. 2024; 196(14):E469–E76.
- Footnote 69
-
Booth, R, Shariff, S, Carter, B, Hwang, S, Orkin, A, Forchuk, C, et al. Opioid-Related Overdose Deaths among People Experiencing Homelessness, 2017 to 2021: A Population-Based Analysis Using Coroner and Health Administrative Data from Ontario, Canada. International Journal of Population Data Science. 2024; 9(5).
- Footnote 70
-
Alsabbagh, M, Cooke, M, Elliott, S, Chang, F, Shah, N, Ghobrial, M. Original Quantitative Research – Stepping up to the Canadian Opioid Crisis: A Longitudinal Analysis of the Correlation between Socioeconomic Status and Population Rates of Opioid-Related Mortality, Hospitalization and Emergency Department Visits (2000–2017). Health Promotion and Chronic Disease Prevention in Canada. 2022; 42(6).
- Footnote 71
-
Carrière, G, Stephenson, E, VanSteelandt, A, Garner, R. Risk Factors for Substance-Related Acute Toxicity Deaths in Canada from 2016 to 2021: Findings from the 2016 Canadian Census Health and Environment Cohort. 2026.
- Footnote 72
-
Andreacchi, A, Carnide, N, Fuller, A, Blair, A, Siddiqi, A, Shahidi, F. Socioeconomic Inequities in Drug Poisoning Deaths in Canada. Canadian Journal of Public Health. 2026.
- Footnote 73
-
Lavalley, J, Kastor, S, Valleriani, J, McNeil, R. Reconciliation and Canada's Overdose Crisis: Responding to the Needs of Indigenous Peoples. Canadian Medical Association Journal. 2018; 190(50):E1466–E7.
- Footnote 74
-
First Nations Health Authority. First Nations and the Toxic Drug Poisoning Crisis in Bc January - December 2025. 2025. Available from: https://www.fnha.ca/Documents/FNHA-First-Nations-and-the-Toxic-Drug-Poisoning-Crisis-in-BC-Jan-Dec-2025.pdf.
- Footnote 75
-
Henderson, R, McInnes, A, Danyluk, A, Wadsworth, I, Healy, B, Crowshoe, L. A Realist Review of Best Practices and Contextual Factors Enhancing Treatment of Opioid Dependence in Indigenous Contexts. Harm Reduction Journal. 2023; 20(1):34.
- Footnote 76
-
Assembly of First Nations. First Nations Health Priorities to Reducing Problematic Opioid Use Discussion Document: A First Nations Specific Opioid Strategy. 2019.
- Footnote 77
-
First Nations Health Authority. Indigenizing Harm Reduction in Response to the Overdose Crisis: Knowledge Gathering with First Nations in BC to Create an Indigenous Harm Reduction Framework. 2025.
- Footnote 78
-
Public Health Agency of Canada. Infectious Syphilis and Congenital Syphilis in Canada, 2023. Canada Communicable Disease Report. 2025; 51(2/3).
- Footnote 79
-
Public Health Agency of Canada. Syphilis: Infection during Pregnancy. 2025. Available from: https://www.canada.ca/en/public-health/services/diseases/syphilis/infection-during-pregnancy.html.
- Footnote 80
-
Nelson, CRM, Ferro, A, Naczk, K, Bitnun, A, Money, D, Narvey, M, et al. Brief Report: Trends of Congenital Syphilis among Neonates in Canada 2012-2023. The Journal of Pediatrics: Clinical Practice. 2025; 16:200146.
- Footnote 81
-
Public Health Agency of Canada. Reported Cases from 1924 to 2023 in Canada - Notifiable Diseases On-Line. 2025.
- Footnote 82
-
Public Health Agency of Canada. Syphilis in Canada: Technical Report on Epidemiological Trends, Determinants and Interventions. 2020.
- Footnote 83
-
Public Health Agency of Canada. Notifiable Diseases Online. Government of Canada; 2025. Available from: https://diseases.canada.ca/notifiable/.
- Footnote 84
-
Public Health Agency of Canada. HIV in Canada, Surveillance Report to December 31, 2023: Executive Summary. 2023. Available from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hiv-canada-surveillance-report-december-31-2023.html.
- Footnote 85
-
Public Health Agency of Canada. HIV in Canada: 2024 Surveillance Highlights. Government of Canada; 2024. Available from: https://www.canada.ca/en/public-health/services/diseases/hiv-aids/health-professionals/surveillance-highlights.html.
- Footnote 86
-
Public Health Agency of Canada. HIV in Canada: 2023 Surveillance Highlights. 2024.
- Footnote 87
-
Public Health Agency of Canada. Canada's Progress Towards Ending the HIV Epidemic. Government of Canada; 2024. Available from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/canada-progress-towards-ending-hiv-epidemic.html.
- Footnote 88
-
Health Infobase. Sexually Transmitted and Blood-Borne Infections: Surveillance Data Dashboard. Government of Canada; 2026. Available from: https://health-infobase.canada.ca/stbbi/surveillance/sti/?di=3.
- Footnote 89
-
Public Health Agency of Canada. Reducing the Health Impact of Sexually Transmitted and Blood-Borne Infections in Canada by 2030: A Pan-Canadian STBBI Framework for Action. 2018.
- Footnote 90
-
Public Health Agency of Canada. Dashboard on the Enhanced Surveillance of Antimicrobial-Resistant Gonorrhea System (ESAG): 2018 to 2024. 2026.
- Footnote 91
-
Public Health Agency of Canada. Government of Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. 2024.
- Footnote 92
-
National Collaborating Centres for Indigenous Health (NCCIH). Sexually Transmitted and Blood-Borne Infections in Indigenous Populations: Background Paper. 2024.
- Footnote 93
-
Keynan, Y, Haworth-Brockman, M, Laupland, KB, Rueda, ZV. Beyond HIV: An Urgent Need for a Syndemic and Gender-Based Approach in the Prairie Provinces in Canada. Journal of the Association of Medical Microbiology and Infectious Disease. 2023; 8(1):1–6.
- Footnote 94
-
Rueda, ZV, Haworth-Brockman, M, Sobie, C, Villacis, E, Larcombe, L, Maier, K, et al. Social and Structural Barriers and Facilitators to HIV Healthcare and Harm Reduction Services for People Experiencing Syndemics in Manitoba: Study Protocol. BMJ Open. 2023; 13(8):e067813.
- Footnote 95
-
Rifai, AA, Pittman Ratterree, DC, Kong, JD, Ndeffo-Mbah, ML. Epidemiological Review on the Resurgence of Measles Outbreaks in Canada during the Post-Elimination Era: A Scoping Review. PLOS Global Public Health. 2026; 6(4):e0006295.
- Footnote 96
-
Public Health Agency of Canada. Measles: For Health Professionals. 2026. Available from: https://www.canada.ca/en/public-health/services/diseases/measles/health-professionals-measles.html.
- Footnote 97
-
Health Infobase. Measles and Rubella Weekly Monitoring Report (2025). Government of Canada; 2026. Available from: https://health-infobase.canada.ca/measles-rubella/archive/2025/.
- Footnote 98
-
Public Health Ontario. Enhanced Epidemiological Summary Measles in Ontario. 2026.
- Footnote 99
-
World Health Organization. Weekly Epidemiological Record. 2025.
- Footnote 100
-
Public Health Agency of Canada. Statement from the Public Health Agency of Canada on Canada's Measles Elimination Status. Government of Canada; 2025. Available from: https://www.canada.ca/en/public-health/news/2025/11/statement-from-the-public-health-agency-of-canada-on-canadas-measles-elimination-status.html.
- Footnote 101
-
Health Infobase. Epidemiological Week 28 (July 12 to 18, 2026) Measles and Rubella Weekly Monitoring Report. Government of Canada; 2026. Available from: https://health-infobase.canada.ca/measles-rubella/.
- Footnote 102
-
Gilbert, NL, Gilmour, H, Wilson, SE, Cantin, L. Determinants of Non-Vaccination and Incomplete Vaccination in Canadian Toddlers. Human Vaccines & Immunotherapeutics. 2017; 13(6):1447–53.
- Footnote 103
-
Wilson, SE, Bunko, A, Johnson, S, Murray, J, Wang, Y, Deeks, SL, et al. The Geographic Distribution of Un-Immunized Children in Ontario, Canada: Hotspot Detection Using Bayesian Spatial Analysis. Vaccine. 2021; 39(8):1349–57.
- Footnote 104
-
Jeevakanthan, A, Roubos, S, Hong, C, Hender, A, Granger, M, Khan, S, et al. Routine Vaccination Coverage at Ages 2 and 7, before, during, and after the COVID-19 Pandemic: Results from the STARVAX Surveillance System. Canadian Journal of Public Health. 2025; 116(2):284–9.
- Footnote 105
-
Public Health Agency of Canada. Vaccination Coverage in Children. Standardized Reporting on Vaccination (STARVAX). Health Infobase; 2026. Available from: https://health-infobase.canada.ca/vaccination-coverage/starvax/children.html.
- Footnote 106
-
Public Health Agency of Canada. Highlights from the 2021 Childhood National Immunization Coverage Survey (CNICS). 2024. Available from: https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage/2021-highlights-childhood-national-immunization-coverage-survey.html#coverage.
- Footnote 107
-
Tiwana, MH, Smith, J. Structural Determinants of Vaccine Access: An Integrated Review of the Canadian Literature. Vaccine. 2026; 76:128324.
- Footnote 108
-
World Health Organization. Behavioural and Social Drivers of Vaccination: Tools and Practical Guidance for Achieving High Uptake. 2022.
- Footnote 109
-
Public Health Agency of Canada. Realizing the Future of Vaccination for Public Health. The Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2024. 2024.
- Footnote 110
-
National Collaborating Centre for Methods and Tools. Rapid Review Update 1: What Is Known About Reasons for Vaccine Confidence and Uptake in Populations Experiencing Inequities? 2024.
- Footnote 111
-
Canadian Cancer Statistics Advisory Committee; Canadian Cancer Society; Statistics Canada; Public Health Agency of Canada. Canadian Cancer Statistics 2025. Toronto, ON: 2025.
- Footnote 112
-
Brenner, DR, Gillis, J, Demers, A, Ellison, LF, Ng, C, Zhang, SX, et al. Projected Estimates of Cancer in Canada in 2026. Canadian Medical Association Journal. 2026; 198(14):E526–E34.
- Footnote 113
-
Nicolau, IA, Warkentin, MT, Graff, K, Doll, C, Bryant, H, Brenner, DR. Increasing Cervical Cancer Rates among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022. JCO Oncology Advances. 2025; (2):e2400101.
- Footnote 114
-
O'Sullivan, DE, Hilsden, RJ, Ruan, Y, Forbes, N, Heitman, SJ, Brenner, DR. The Incidence of Young-Onset Colorectal Cancer in Canada Continues to Increase. Cancer Epidemiology. 2020; 69:101828.
- Footnote 115
-
Akimoto, N, Ugai, T, Zhong, R, Hamada, T, Fujiyoshi, K, Giannakis, M, et al. Rising Incidence of Early-Onset Colorectal Cancer - A Call to Action. Nature Reviews Clinical Oncology. 2021; 18(4):230–43.
- Footnote 116
-
Ugai, T, Sasamoto, N, Lee, HY, Ando, M, Song, M, Tamimi, RM, et al. Is Early-Onset Cancer an Emerging Global Epidemic? Current Evidence and Future Implications. Nature Reviews Clinical Oncology. 2022; 19(10):656–73.
- Footnote 117
-
Seely, JM, Ellison, LF, Billette, JM, Zhang, SX, Wilkinson, AN. Incidence of Breast Cancer in Younger Women: A Canadian Trend Analysis. Canadian Association of Radiologists Journal. 2024; 75(4):847–54.
- Footnote 118
-
Yuill, S, Naidu, C, Smith, M, Bateson, D, Saville, M, Damutalau, B, et al. Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers. Med J Aust. 2026; 224(4):e70164.
- Footnote 119
-
Pataky, RE, Izadi-Najafabadi, S, Smith, LW, Gottschlich, A, Ionescu, D, Proctor, L, et al. Strategies to Accelerate the Elimination of Cervical Cancer in British Columbia, Canada: A Modelling Study. CMAJ. 2024; 196(21):E716–E23.
- Footnote 120
-
Hall, MT, Hyatt, A, Smith, MA, Torode, J, Costa, T, Nguyen, DTN, et al. Elimination of Cervical Cancer: The Impact of HPV Vaccination, Primary HPV Screening, and Expanded Access to Cancer Treatment Services. Molecular Aspects of Medicine. 2026; 107:101423.
- Footnote 121
-
Sarfati, D. Chapter 3 Why Social Inequalities Matter in the Cancer Continuum. In: Vaccarella, S, Lortet-Tieulent, J, Saracci, R, et al., editor. Reducing Social Inequalities in Cancer: Evidence and Priorities for Research. Lyon, France: IARC Scientific Publications, No. 168; 2019.
- Footnote 122
-
Statistics Canada. Lifetime Probability of Developing and Dying from Cancer in Canada. Government of Canada; 2023. Available from: https://www.statcan.gc.ca/o1/en/plus/4547-lifetime-probability-developing-and-dying-cancer-canada.
- Footnote 123
-
Statistics Canada. Table 13-10-0394-01 Leading Causes of Death, Total Population, by Age Group. Government of Canada; 2026. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310039401.
- Footnote 124
-
Statistics Canada. Population Projections for Canada, Provinces and Territories, 2021 to 2068, 2022. The Daily; 2022. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/220822/dq220822b-eng.htm.
- Footnote 125
-
Kirchmeier-Young, MC, Malinina, E, Barber, QE, Garcia Perdomo, K, Curasi, SR, Liang, Y, et al. Human Driven Climate Change Increased the Likelihood of the 2023 Record Area Burned in Canada. NPJ Climate and Atmospheric Science. 2024; 7(1):316.
- Footnote 126
-
Barnes, C, Boulanger, Y, Keeping, T, Gachon, P, Gillett, N, Boucher, J, et al. Climate Change More Than Doubled the Likelihood of Extreme Fire Weather Conditions in Eastern Canada. 2023.
- Footnote 127
-
Bush, E, Lemmen, DS. Canada's Changing Climate Report. Ottawa, ON: 2019.
- Footnote 128
-
Hanes, CC, Jain, P, Wang, W, Wang, X, Parisien, MA, Little, JM, et al. Fire Regime Changes in Canada: An Update. Canadian Journal of Forest Research. 2025; 55:1–11.
- Footnote 129
-
Natural Resources Canada. Climate Change and Wildland Fire. 2026.
- Footnote 130
-
Canadian Interagency Forest Fire Centre Inc. Wildfire Graphs. 2026. Available from: https://ciffc.net/statistics.
- Footnote 131
-
Bénichou, N, Adelzadeh, M, Singh, J, Gomaa, I, Elsagan, N, Kinateder, M, et al. National Guide for Wildland-Urban-Interface Fires: Guidance on Hazard and Exposure Assessment, Property Protection, Community Resilience and Emergency Planning to Minimize the Impact of Wildland-Urban Interface Fires. 2021.
- Footnote 132
-
Berry, P, Schnitter, R. Health of Canadians in a Changing Climate: Advancing Our Knowledge for Action. Ottawa, ON: 2022.
- Footnote 133
-
Pacey, L, Murti, M, Groot, E, Ahmed, W, Aloosh, M. Approach to Wildfire-Related Health Impacts. Canadian Family Physician. 2026; 72.
- Footnote 134
-
Christianson, AC, Johnston, LM, Oliver, JA, Watson, D, Young, D, MacDonald, H, et al. Wildland Fire Evacuations in Canada from 1980 to 2021. International Journal of Wildland Fire. 2024; 33(7).
- Footnote 135
-
Canadian Forest Service. Canadian Wildland Fire Information System (CWFIS). Natural Resources Canada, Canadian Forest Service, Northern Forestry Centre; 2025. Available from: https://cwfis.cfs.nrcan.gc.ca/en/.
- Footnote 136
-
Public Health Agency of Canada. Rapid Review: An Intersectional Analysis of the Disproportionate Health Impacts of Wildfires on Diverse Populations and Communities. 2024.
- Footnote 137
-
Brown, M, Brown, M. Economic and Social Reports. Estimates of Gross Domestic Product in Wildfire-Affected Areas during the 2023 and 2024 Wildfire Seasons. Statistics Canada; 2025. Available from: https://www150.statcan.gc.ca/n1/pub/36-28-0001/2025006/article/00004-eng.htm.
- Footnote 138
-
National Collaborating Centres for Public Health. Health and Social Impacts of Long-Term Evacuation Due to Natural Disasters in First Nations Communities: A Summary of Lessons for Public Health. 2021.
- Footnote 139
-
Waddell, K, Wu, N, Ciurea, P, Demaio, P, Bain, T, Ahmed, A, et al. Rapid Evidence Profile #74: Examining the Health and Social Impacts of Evacuations and Interventions That Can Help to Mitigate Their Effects. Hamilton: 2024.
- Footnote 140
-
Hertelendy, AJ, Howard, C, Sorensen, C, Ranse, J, Eboreime, E, Henderson, S, et al. Seasons of Smoke and Fire: Preparing Health Systems for Improved Performance before, during, and after Wildfires. The Lancet Planetary Health. 2024; 8(8):E588–E602.
- Footnote 141
-
Public Health Agency of Canada. Creating the Conditions for Resilient Communities: A Public Health Approach to Emergencies. Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2023. 2023.
- Footnote 142
-
Hohban, L, Strong, K, Trottier, S, Larocque, H. Wildfire Experiences among Indigenous Peoples. Statistics Canada; 2026. Available from: https://www150.statcan.gc.ca/n1/pub/16-002-x/2026001/article/00002-eng.htm.
- Footnote 143
-
Mihalus, S, Galway, LP, Robinson, LW, Duckert, D, Parenteau, D. Wildfire Management and Evacuation in Indigenous Communities in Canada and the United States: A Scoping Review. International Journal of Disaster Risk Reduction. 2024; 100:104170.
- Footnote 144
-
McGee, TK. Evacuating First Nations during Wildfires in Canada. Fire Safety Journal. 2021; 120:103120.
- Footnote 145
-
Montesanti, S, Fitzpatrick, K, Azimi, T, McGee, T, Fayant, B, Albert, L. Exploring Indigenous Ways of Coping after a Wildfire Disaster in Northern Alberta, Canada. Qual Health Res. 2021; 31(8):1472–85.
- Footnote 146
-
Christianson, AC, Sutherland, CR, Moola, F, Gonzalez Bautista, N, Young, D, MacDonald, H. Centering Indigenous Voices: The Role of Fire in the Boreal Forest of North America. Current Forestry Reports. 2022; 8(3):257–76.
- Footnote 147
-
Hoffman, KM, Cardinal Christianson, A, Dickson-Hoyle, S, Copes-Gerbitz, K, Nikolakis, W, Diabo, DA, et al. The Right to Burn: Barriers and Opportunities for Indigenous-Led Fire Stewardship in Canada. FACETS. 2022; 7:464–81.
- Footnote 148
-
FireSmart Canada. Blazing the Trail: Celebrating Indigenous Fire Stewardship. 2024.
- Footnote 149
-
Health Canada. Human Health Effects of Wildfire Smoke. 2024.
- Footnote 150
-
British Columbia Ministry of Emergency Management and Climate Readiness. Understanding Disaster and Climate Risks in B.C. 2026. Available from: https://climatereadybc.gov.bc.ca/pages/dcrra.
- Footnote 151
-
Public Health Agency of Canada. Mobilizing Public Health Action on Climate Change in Canada. Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2022. 2022.
